Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Invite your friends, family, colleagues or clients to an exceptional black-tie event in the heart of London. Every ticket, every bid, every moment helps us move closer to a cure.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Join the type 1 diabetes community and come together, raising awareness and vital funds for T1D.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > Type 1 Discovery magazine – free copy
Published three times a year, Type 1 Discovery is packed with features, news, updates and ways to get involved with JDRF. The current issue includes features on:
Sign up using the form below and receive your first free copy of Type 1 Discovery soon!
We’d love to keep you updated on how your support is helping to cure, treat and prevent type 1 diabetes. We will send you information about our work, events, ways to get involved and fundraising. Simply let us know how you’d like to hear from us.
We respect your privacy. We will never share your information with any third party. For full details see our privacy policy.
We’re pleased to announce that we are launching a new initiative to raise awareness of the importance of early detection in type 1 diabetes (T1D), with support from Sanofi.
In a landmark moment, the MHRA has licensed the use of teplizumab in the UK, the first-ever disease-modifying therapy for T1D.
Steve Bates OBE, David Bruce and Dean Sowman will join our Board of Directors in October 2025.
In the study, nearly two thirds of young people diagnosed with type 1 diabetes (T1D) did not have the typical identifiers of the condition.
